Adam Soll, MD | |
1200 Ne 48th Ave, Suite #1100, Hillsboro, OR 97124 | |
(503) 844-8310 | |
(503) 844-8316 |
Full Name | Adam Soll |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 21 Years |
Location | 1200 Ne 48th Ave, Hillsboro, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689878100 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | MD28704 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tuality Community Hospital | Hillsboro, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Tuality Medical Group Llc | 7416173414 | 245 |
News Archive
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
Women are almost twice as likely to experience anxiety as men, according to a review of existing scientific literature, led by the University of Cambridge. The study also found that people from Western Europe and North America are more likely to suffer from anxiety than people from other cultures.
Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
› Verified 9 days ago
Entity Name | Tuality Healthcare |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
Women are almost twice as likely to experience anxiety as men, according to a review of existing scientific literature, led by the University of Cambridge. The study also found that people from Western Europe and North America are more likely to suffer from anxiety than people from other cultures.
Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
› Verified 9 days ago
Entity Name | Tuality Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
Women are almost twice as likely to experience anxiety as men, according to a review of existing scientific literature, led by the University of Cambridge. The study also found that people from Western Europe and North America are more likely to suffer from anxiety than people from other cultures.
Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Adam Soll, MD 1200 Ne 48th Ave, Suite #1100, Hillsboro, OR 97124 Ph: (503) 844-8310 | Adam Soll, MD 1200 Ne 48th Ave, Suite #1100, Hillsboro, OR 97124 Ph: (503) 844-8310 |
News Archive
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
Women are almost twice as likely to experience anxiety as men, according to a review of existing scientific literature, led by the University of Cambridge. The study also found that people from Western Europe and North America are more likely to suffer from anxiety than people from other cultures.
Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.
The American Jewish Committee urged the Egyptian government to allow a team of Israeli breast cancer researchers to enter the country for a major conference sponsored by Susan G. Komen for the Cure, a leading breast cancer awareness group based in the U.S. The Israeli team was denied entry into Egypt earlier this week, despite having previously received the necessary clearances to attend the conference in Alexandria.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
› Verified 9 days ago